| Ident. | Authors (with country if any) | Title |
|---|
| 000003 (2021) |
Joshuan J. Barboza [Pérou] ; Diego Chambergo-Michilot [Pérou] ; Mariana Velasquez-Sotomayor [Pérou] ; Christian Silva-Rengifo [Pérou] ; Carlos Diaz-Arocutipa [Pérou] ; Jose Caballero-Alvarado [Pérou] ; Franko O. Garcia-Solorzano [Pérou] ; Christoper A. Alarcon-Ruiz [Pérou] ; Leonardo Albitres-Flores [Pérou] ; German Malaga [Pérou] ; Patricia Schlagenhauf [Suisse] ; Alfonso J. Rodriguez-Morales [Colombie] | Assessment and management of asymptomatic COVID-19 infection: A systematic review. |
| 000014 (2021) |
Julio Echarte-Morales [Espagne] ; Carlos Minguito-Carazo [Espagne] ; Samuel Del Castillo-García [Espagne] ; Javier Borrego-Rodríguez [Espagne] ; Miguel Rodríguez-Santamarta [Espagne] ; Enrique Sánchez-Mu Oz [Espagne] ; Rubén Bergel-García [Espagne] ; Clea González-Maniega [Espagne] ; Silvia Prieto-González [Espagne] ; Paula Menéndez-Suarez [Espagne] ; Elena Tundidor-Sanz [Espagne] ; Tomás Benito-González [Espagne] ; Felipe Fernández-Vázquez [Espagne] | Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19. |
| 000020 (2021) |
Fabio Cruciani [Italie] ; Laura Amato [Italie] ; Franco De Crescenzo ; Zuzana Mitrova [Italie] ; Rosella Saulle [Italie] ; Simona Vecchi [Italie] ; Marina Davoli [Italie] | [The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.] |
| 000022 (2021) |
E. Díaz [Espagne] ; R. Amézaga Menéndez [Espagne] ; P. Vidal Cortés [Espagne] ; M G Escapa [Espagne] ; B. Suberviola [Espagne] ; A. Serrano Lázaro [Espagne] ; P. Marcos Neira [Espagne] ; M. Quintana Díaz [Espagne] ; M. Catalán González [Espagne] | [Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)]. |
| 000035 (2021) |
L. Anedda [Italie] ; L. Bianchini ; L. Cuzzolin ; G. Finco ; V. Fanos ; M A Marcialis | What if COVID-19 affects the child: which weapons and how to use them. |
| 000043 (2021) |
Albert Prats-Uribe [Royaume-Uni] ; Anthony G. Sena [États-Unis, Pays-Bas] ; Lana Yin Hui Lai [Royaume-Uni] ; Waheed-Ul-Rahman Ahmed [Royaume-Uni] ; Heba Alghoul ; Osaid Alser [États-Unis] ; Thamir M. Alshammari [Arabie saoudite] ; Carlos Areia [Royaume-Uni] ; William Carter [États-Unis] ; Paula Casajust [Espagne] ; Dalia Dawoud [Égypte, Royaume-Uni] ; Asieh Golozar [États-Unis] ; Jitendra Jonnagaddala [Australie] ; Paras P. Mehta [États-Unis] ; Mengchun Gong [République populaire de Chine] ; Daniel R. Morales [Royaume-Uni, Danemark] ; Fredrik Nyberg [Suède] ; Jose D. Posada [États-Unis] ; Martina Recalde [Espagne] ; Elena Roel [Espagne] ; Karishma Shah [Royaume-Uni] ; Nigam H. Shah [États-Unis] ; Lisa M. Schilling [États-Unis] ; Vignesh Subbian [États-Unis] ; David Vizcaya [Espagne] ; Lin Zhang [République populaire de Chine, Australie] ; Ying Zhang [République populaire de Chine] ; Hong Zhu [République populaire de Chine] ; Li Liu [République populaire de Chine] ; Jaehyeong Cho [Corée du Sud] ; Kristine E. Lynch [États-Unis] ; Michael E. Matheny [États-Unis] ; Seng Chan You [Corée du Sud] ; Peter R. Rijnbeek [Pays-Bas] ; George Hripcsak [États-Unis] ; Jennifer Ce Lane [Royaume-Uni] ; Edward Burn [Royaume-Uni, Espagne] ; Christian Reich [États-Unis] ; Marc A. Suchard [États-Unis] ; Talita Duarte-Salles [Espagne] ; Kristin Kostka [États-Unis] ; Patrick B. Ryan [Slovénie, États-Unis] ; Daniel Prieto-Alhambra [Royaume-Uni] | Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study. |
| 000091 (2021) |
Fatemeh Sadat Hosseini [Iran] ; Alireza Malektojari [Iran] ; Sara Ghazizadeh [Iran] ; Mehdi Hassaniazad [Iran] ; Parivash Davoodian [Iran] ; Habib Dadvand [Iran] ; Amin Reza Nikpoor [Iran] ; Sara Nikoofal-Sahlabadi [Iran] ; Sara Kahoori [Iran] ; Mojtaba Sepandi [Iran] ; Soheil Hassanipour [Iran] ; Mohammad Fathalipour [Iran] | The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial. |
| 000114 (2021) |
Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Bhanuprasad Venkatesalu [États-Unis] ; Harsh K. Patel [États-Unis] ; Marco Spadaccini [Italie] ; Jacob Manteuffel [États-Unis] ; Mayur Ramesh [États-Unis] | Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection. |
| 000136 (2021) |
T Y Andy Ko [Malaisie] ; L S Chen [Malaisie] ; I X Pang [Malaisie] ; H S Ling [Malaisie] ; T C Wong [Malaisie] ; L L Sia Tonnii [Malaisie] ; K T Koh [Malaisie] | Smartphone electrocardiogram for QT interval monitoring in Coronavirus Disease 2019 (COVID-19) patients treated with Hydroxychloroquine. |
| 000138 (2021) |
Katharina Habler [Allemagne] ; Mathias Brügel [Allemagne] ; Daniel Teupser [Allemagne] ; Uwe Liebchen [Allemagne] ; Christina Scharf [Allemagne] ; Ulf Schönermarck [Allemagne] ; Michael Vogeser [Allemagne] ; Michael Paal [Allemagne] | Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum. |
| 000160 (2021) |
Saeidreza Jamalimoghadamsiahkali [Iran] ; Besharat Zarezade [Iran] ; Sogol Koolaji [Iran] ; Seyedahmad Seyedalinaghi [Iran] ; Abolfazl Zendehdel [Iran] ; Mohammad Tabarestani [Iran] ; Ehsan Sekhavati Moghadam [Iran] ; Ladan Abbasian [Iran] ; Seyed Ali Dehghan Manshadi [Iran] ; Mohamadreza Salehi [Iran] ; Malihe Hasannezhad [Iran] ; Sara Ghaderkhani [Iran] ; Mohsen Meidani [Iran] ; Faeze Salahshour [Iran] ; Fatemeh Jafari [Iran] ; Navid Manafi [Canada] ; Fereshteh Ghiasvand [Iran] | Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial. |
| 000231 (2021) |
Venkata R. Emani [États-Unis] ; Sanjeev Goswami [États-Unis] ; Dheeraj Nandanoor [États-Unis] ; Shaila R. Emani [États-Unis] ; Nidhi K. Reddy [États-Unis] ; Raghunath Reddy [États-Unis] | Randomised controlled trials for COVID-19: evaluation of optimal randomisation methodologies-need for data validation of the completed trials and to improve ongoing and future randomised trial designs. |
| 000234 (2021) |
Carlos Diaz-Arocutipa [Pérou] ; Ana Bra Ez-Condorena [Pérou] ; Adrian V. Hernandez [Pérou, États-Unis] | QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis. |
| 000246 (2021) |
Jacobo Rogado [Espagne] ; Pedro Gull N [Espagne] ; Berta Obispo [Espagne] ; Gloria Serrano [Espagne] ; Miguel Lara [Espagne] | Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors. |
| 000253 (2021) |
Leila Simani [Iran] ; Mahtab Ramezani [Iran] ; Ilad Alavi Darazam [Iran] ; Mastooreh Sagharichi [Iran] ; Mohammad Amin Aalipour [Iran] ; Fatemeh Ghorbani [Iran] ; Hossein Pakdaman [Iran] | Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. |
| 000294 (2021) |
Sanjay Kumar Mishra [Inde] ; Timir Tripathi [Inde] | One year update on the COVID-19 pandemic: Where are we now? |
| 000295 (2021) |
Zheng Zequn [République populaire de Chine] ; Wu Yujia [République populaire de Chine] ; Qian Dingding [République populaire de Chine] ; Lian Jiangfang [République populaire de Chine] | Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel. |
| 000297 (2021) |
Havva Kocayi It [Turquie] ; Kezban Özmen Süner [Turquie] ; Yakup Tomak [Turquie] ; Gürkan Demir [Turquie] ; Selçuk Yaylac [Turquie] ; Hamad Dheir [Turquie] ; Ertu Rul Güçlü [Turquie] ; Ali Fuat Erdem [Turquie] | Observational study of the effects of Favipiravir vs Lopinavir/Ritonavir on clinical outcomes in critically Ill patients with COVID-19. |
| 000307 (2021) |
Shweta A. More [Inde] ; Akshay S. Patil [États-Unis] ; Nikhil S. Sakle [Inde] ; Santosh N. Mokale [Inde] | Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs. |
| 000338 (2021) |
Florence Rodgers [Royaume-Uni] ; Toby Pepperrell [Royaume-Uni] ; Sarai Keestra [Pays-Bas, Royaume-Uni] ; Victoria Pilkington [Royaume-Uni] | Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs. |
| 000353 (2021) |
Ji-Won Kim [Corée du Sud] ; Eun Jin Kim [Corée du Sud] ; Hyun Hee Kwon [Corée du Sud] ; Chi Young Jung [Corée du Sud] ; Kyung Chan Kim [Corée du Sud] ; Jung-Yoon Choe [Corée du Sud] ; Hyo-Lim Hong [Corée du Sud] | Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019. |
